ArticleOncogene2013
IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.
M Cortés-Sempere et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papercites it